Akero Therapeutics MASH Treatment Trial Data: Stock Up 21%
The stock has dropped 29% in the last year, hitting a low of $11.25 on Oct. 27. A study shows ...
- Latest
- Trending
The stock has dropped 29% in the last year, hitting a low of $11.25 on Oct. 27. A study shows ...
The cryptocurrency industry, backed by major players like Coinbase and the Winklevoss twins, is actively involved in the 2024 U.S. ...
Paco Martin, Group Head of Open RAN at Vodafone, stated that they are continuously working to find the best RAN ...
Amlan showcased its unique mineral technology at the World Dairy Expo, with trials demonstrating improvements in milk production and animal ...
The University of Missouri has implemented policies on the use of artificial intelligence in student assignments, including guidelines for AI ...
ShockWave Medical Inc. achieved record revenue growth in 2023, forecasting further expansion in 2024. Strategic moves and new product launches ...
Incannex Healthcare makes breakthrough in smoking cessation drug program as FDA approves clinical trials for CannQuit-N chewing gum.
PetVivo Holdings reports strong Q3 results and clinical study advancements, including a non-exclusive distribution agreement and positive outcomes for its ...
A AAA study reveals limitations in Reverse AEB technology, showing it is only effective in preventing collisions about 50% of ...
A Louisiana woman files lawsuit against Amazon and pharmaceutical companies over contaminated eye drops leading to severe injuries. Consumer trust ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.